Pharmaceutical Products Registration Requirements for ASEAN and GCC Countries
DOI:
https://doi.org/10.37591/tdd.v1i3.267Abstract
Registration of pharmaceutical products is a challenge and an important task in regulated, semi regulated as well as rest of the world countries. Although the requirements are harmonized in regulated countries by Common Technical Document (CTD) filing, yet others have enormous diversity in requirements. The purpose of the present study is to understand the requirements for registration of drug products in countries like the Association of South East Asian Nation (ASEAN) and Gulf Cooperation Council (GCC).In the ASEAN and GCC region, A-CTD filling procedure and CTD format is used, respectively. The optimization in requirements is mandatory and can be judged by the incidence of higher cost involved in the availability of drugs, research and development facilities. For better treatment, safety and efficacy the drugs must be justified and rationalized for public security. The study also provides the challenges and barriers faced by the emerging markets (ASEAN). The commercial significance of markets is increasing globally. It is vital for pharmaceutical industry to cope with the regulatory requirements for betterment of public and ensure their place in the market.
Keywords: CTD, ACTD, ASEAN, GCC
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |